Mutations in the alpha-synuclein gene can cause increased vulnerability to pesticides, which may lead to Parkinson’s disease.
Researchers discover the expression of certain clock genes plays a critical role in delaying the emergence of age-related signs in the brain.
Researchers use RNAi to reveal dozens of genes which could represent new therapeutic targets for treating Parkinson’s disease.
Researchers use a novel sequencing method to identify a group of genes used by microglia to sense pathogenic organisms, toxins and damaged neurons.
Researchers have discovered a volatile organic compound, 1-octen-3-ol, which is often emitted by mold, could be linked to the symptoms of Parkinson’s disease.
A new study links a lack of SMG1 to protein aggregates associated with Parkinson’s disease and other neurodegenerative diseases.
Researchers studying the cause of A-T disease believe their findings could provide new clues to understanding neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
Researchers create neurons from the skin cells of ALS patients in order to “treat” a gene defect in a dish.
Researchers discover SMEK1 promotes the differentiation of neural stem and progenitor cells while, at the same time, keeping these cells in check by suppressing their uncontrolled proliferation.
Researchers have identified a novel Parkinson’s disease drug target and a compound capable of repairing neurons derived from Parkinson’s patients.